Oral vinorelbine in metastatic breast cancer

被引：0
|
作者：
PF Conte
S Giovannelli
机构：
[1] University Hospital,Division of Medical Oncology, Department of Oncology and Haematology
[2] University of Modena and Reggio Emilia,undefined
来源：
Breast Cancer Research | / 7卷 / Suppl 1期
关键词：
Neutropenia; Docetaxel; Trastuzumab; Metastatic Breast Cancer; Capecitabine;
D O I：
10.1186/bcr1229
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Efficacy and safety of oral vinorelbine in advanced breast cancer
    Silva, S.
    Winter, M. C.
    Din, O. S.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S184 - S184
  • [42] Real-life activity of oral vinorelbine in metastatic breast cancer patients in the Unicancer ESME database
    Pierre, H.
    Mahasti, S.
    Damien, P.
    Nicolas, M.
    Chritelle, L.
    Florence, D.
    Mony, U.
    Lionel, U.
    William, J.
    Paule, A.
    Audrey, M.
    Claudia, L.
    Mario, C.
    Marie-Paule, S.
    Marie-Ange, M-R
    Marianne, L.
    Jean-Christophe, E.
    Thierry, P.
    Jean-Marc, F.
    Bruno, C.
    Anthony, G.
    Christian, C.
    Gaetane, S.
    David, P.
    CANCER RESEARCH, 2017, 77
  • [43] METRONOMIC ORAL VINORELBINE IN PATIENTS WITH METASTATIC BREAST CANCER (MBC): A PHASE II STUDY IN OUR INSTITUTION
    Nastasi, G.
    Cotroneo, G.
    Roda, G.
    Duluc, M.
    Castro, A.
    Maffioletti, L.
    Ravenda, P. S.
    ANNALS OF ONCOLOGY, 2009, 20
  • [44] Optimizing clinical care of patients with metastatic breast cancer:: a new oral vinorelbine plus trastuzumab combination
    Catania, C.
    Medici, M.
    Magni, E.
    Munzone, E.
    Cardinale, D.
    Adamoli, L.
    Sanna, G.
    Minchella, I.
    Radice, D.
    Goldhirsch, A.
    Nole, F.
    ANNALS OF ONCOLOGY, 2007, 18 (12) : 1969 - 1975
  • [45] Can the Day 8 Blood Test Be Omitted for Patients Receiving Oral Vinorelbine for Metastatic Breast Cancer?
    Thomas, R.
    Khunti, R.
    Williams, M.
    Glen, J.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : S157 - S157
  • [46] Phase II study of an all-oral combination of vinorelbine with capecitabine in patients with metastatic breast cancer
    Franco Nolè
    D. Crivellari
    R. Mattioli
    G. Pinotti
    P. Foa
    E. Verri
    R. Fougeray
    M. Brandely
    A. Goldhirsch
    Cancer Chemotherapy and Pharmacology, 2009, 64 : 673 - 680
  • [47] Phase II study of an all-oral combination of vinorelbine with capecitabine in patients with metastatic breast cancer
    Nole, Franco
    Crivellari, D.
    Mattioli, R.
    Pinotti, G.
    Foa, P.
    Verri, E.
    Fougeray, R.
    Brandely, M.
    Goldhirsch, A.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 64 (04) : 673 - 680
  • [48] Epirubicin/vinorelbine as first line therapy in metastatic breast cancer
    Baldini, E
    Tibaldi, C
    Chiavacci, F
    Di Lieto, M
    Fioretto, L
    Giallombardo, A
    Taviani, R
    Ghezzi, P
    Bolognini, A
    Conte, P
    BREAST CANCER RESEARCH AND TREATMENT, 1998, 49 (02) : 129 - 134
  • [49] Mitoxantrone plus vinorelbine in pretreated patients with metastatic breast cancer
    Onyenadum, A.
    Gogas, H.
    Markopoulos, C.
    Bafaloukos, D.
    Aravantinos, G.
    Mantzourani, M.
    Koutras, A.
    Tzorakoelefterakis, E.
    Xiros, N.
    Makatsoris, T.
    Fountzilas, G.
    Kalofonos, H. P.
    JOURNAL OF CHEMOTHERAPY, 2007, 19 (05) : 582 - 589
  • [50] Epirubicin/vinorelbine as first line therapy in metastatic breast cancer
    Editta Baldini
    Carmelo Tibaldi
    Franco Chiavacci
    Marco Di Lieto
    Luisa Fioretto
    Annalia Giallombardo
    Roberto Taviani
    Paolo Ghezzi
    Anna Bolognini
    Pierfranco Conte
    Breast Cancer Research and Treatment, 1998, 49 : 129 - 134
12345